{"name":"Robert Flavell, MD, PhD","slug":"robert-flavell-md-phd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"89Zr-DFO-YS5","genericName":"89Zr-DFO-YS5","slug":"89zr-dfo-ys5","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"89Zr-DFO-YS5","genericName":"89Zr-DFO-YS5","slug":"89zr-dfo-ys5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1EQl9Nd0NBM0R3SnNyU3Rsc0trVHdkWHVxSW1KXzI3a0JFTVVyMUlTblVTNFpZc0lUcmMtVWJmSG92ZldtX0o0OTEtUzhlWTYySElUM0lldklyUkdZ?oc=5","date":"2026-03-22","type":"pipeline","source":"EurekAlert!","summary":"Anil Parsram Bidkar, PhD, receives SNMMI-PCF Young Investigator's Award - EurekAlert!","headline":"Anil Parsram Bidkar, PhD, receives SNMMI-PCF Young Investigator's Award - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPQnBlWE9UQ2FYbGZMQUxKaUtDSTNaRDVuVkIxMXdOTlVLaU5PZUNtNXJsX3puTXlsb0JwNU1uLVJEakM2XzMzWE5BTXhJb2VEemxEeG5VWnVJQ2JBQWNsYU1qaGp0WnFJejNFUFRER2RaMjRicWxPbGhta05lR3BtNmtiaWxRQzRMY1QtUkhrSlVadXBVdlRtamdDRmZ3eFA5ZWN5c2dfNUFleGZTOUFsMW5vT3BmTV9HUnNWY05IY0NSemZJYmFDenJnYk1PRHR2d0tuaEZzV2ZyOVlIbWJjN20yZDMyalVQMVE0djE4YTk3aEgwMzI2cGxESUExSlBBTkNJOV9zM3ZadkFHZ1BZ?oc=5","date":"2025-04-29","type":"pipeline","source":"UroToday","summary":"Beyond PSMA: Targets for Prostate Cancer Radiopharmaceutical Therapy \"Presentation\" - Robert Flavell - UroToday","headline":"Beyond PSMA: Targets for Prostate Cancer Radiopharmaceutical Therapy \"Presentation\" - Robert Flavell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOREx2NDhlX3R1a2ZQTnB4alVyM2JIZVdvb1pURUJUckx4NmkzaVNwTWItd0pCSkpCSDZJTG5ZeS1NVWJCYUdZaHA4dFhPcGVMN29GczNFTDhsZW5pSXBBRWpqNnhlaHBrZXR1Sk5mRTJKcldzZHNPS1pTeGs0LWxVRGZ3UnpwRENWUmo5bTZzMGFkOGVLVm43d2dVUlg4SXZRTkpydFdlNWRjZnNmZS1aa1paWUVnbVRDcUZZ?oc=5","date":"2024-12-19","type":"deal","source":"Stock Titan","summary":"Shuttle Pharmaceuticals Partners with UCSF for Breakthrough Prostate Cancer Diagnostic Development - Stock Titan","headline":"Shuttle Pharmaceuticals Partners with UCSF for Breakthrough Prostate Cancer Diagnostic Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNY296SFo3emdjUl9ZNFNvZ251dlNmaXZzTUVRcDBPVFhuMEgxOTVjNVRESGJBMERFalB2ajFEZFhKdHNrOFlqdnVCWXRReXEtTUt4TGIwQTFGSmNLTHJvTTZKazVZeVNqM1pCU25sTjItU3d0YUFISGVManQtT2tnTUU0VkhaMzdzdTJzZFZSQm93bTJMdzVxYXY4RXQyTC0tTEZ4cm93UmVIUExrdi1fY29SOWV4c1NrVTBkdlYxTUxXTi1ZVzR5U2stQW4zYzMxZEhCQ3hkcGVoWHdHaFhpR1RycjBmZFEtWTZELWF2bmpzaUZEMnh2Wm85RDFqVmE0OFNLeExFdkJBSGFfQ3Zua3lMdVVndTJQTjA4YmJ1MXp0Y3lQQmRtbzVzWVJQNkxjUUE?oc=5","date":"2024-02-14","type":"pipeline","source":"UroToday","summary":"Evaluation of Theranostic Prostate Cancer Targets with Antibody Based Radiopharmaceuticals “Presentation” - Robert Flavell - UroToday","headline":"Evaluation of Theranostic Prostate Cancer Targets with Antibody Based Radiopharmaceuticals “Presentation” - Robert Flave","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPLUl6Wk9ZNkNLSkdXby1GZDRLREJTOXlhLUtLUmtpVFNvUVlsTWlLNUlYQldQcG5Ma0JhWWs5SkZEaFEtYWRMS0RBWDRVNFUwc0F5S1p0OWlYVHEwQ0EyeHlUa3hlUVkydjVuck83ZjVyOG83ZktuWHAwS3REOHFlNUh5blFpRTRfSzkyNi1jeTNMVFRXOVFYVy1qSW5nRE84VmlsR0ZKUTlfVDd1c3JrR0Q3TUdFVnhJSDJfMExtME5ETXN5SVVUNmxCeXZ5VVNHRUxUYldnc195dlg0b3JiQWYydWZ3dF9GdjZXOA?oc=5","date":"2024-02-05","type":"pipeline","source":"UroToday","summary":"PSMA Targeted Imaging and Therapy in Prostate Cancer \"Presentation\" - Robert Flavell - UroToday","headline":"PSMA Targeted Imaging and Therapy in Prostate Cancer \"Presentation\" - Robert Flavell","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}